2022 Vol.40, N°3 - Table of contents
March 2022
One year in review
CER15657
2022,40,3
Pg. 0475-0482
Free to view
Pathogenesis of rheumatoid arthritis: one year in review 2022
F. Petrelli, F.M. Mariani, A. Alunno, I. Puxeddu
DOI: https://doi.org/10.55563/clinexprheumatol/l9lyen
F. Petrelli, F.M. Mariani, A. Alunno, I. Puxeddu
DOI: https://doi.org/10.55563/clinexprheumatol/l9lyen
Full Papers
CER14297
2022,40,3
Pg. 0483-0488
Free to view
Effects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease
M. Benad, D. Koschel, K. Herrmann, K. Wiefel, A. Kleymann, M. Aringer
DOI: https://doi.org/10.55563/clinexprheumatol/o5t1f7
M. Benad, D. Koschel, K. Herrmann, K. Wiefel, A. Kleymann, M. Aringer
DOI: https://doi.org/10.55563/clinexprheumatol/o5t1f7
CER14265
2022,40,3
Pg. 0489-0494
Free to view
Change in disease activity is associated with TNF-α inhibitor serum levels in patients with axial spondyloarthritis in daily clinical practice
L. De Wolff, F.R. Wink, H. Bootsma, S. Arends, A. Spoorenberg
DOI: https://doi.org/10.55563/clinexprheumatol/yzeh9b
L. De Wolff, F.R. Wink, H. Bootsma, S. Arends, A. Spoorenberg
DOI: https://doi.org/10.55563/clinexprheumatol/yzeh9b
CER14208
2022,40,3
Pg. 0495-0500
Lung ultrasound in patients with rheumatoid arthritis: definition of significant interstitial lung disease
M. Di Carlo, M. Tardella, E. Filippucci, M. Carotti, F. Salaffi
DOI: https://doi.org/10.55563/clinexprheumatol/gioptt
M. Di Carlo, M. Tardella, E. Filippucci, M. Carotti, F. Salaffi
DOI: https://doi.org/10.55563/clinexprheumatol/gioptt
CER14093
2022,40,3
Pg. 0501-0513
Resistin induces chemokine and matrix metalloproteinase production via CAP1 receptor and activation of p38-MAPK and NF-κB signalling pathways in human chondrocytes
C.-W. Zhao, W.-X. Song, B. Liu, Y.-H. Gao, L. Ding, Y.-F. Huang, X. Qi
DOI: https://doi.org/10.55563/clinexprheumatol/avcj31
C.-W. Zhao, W.-X. Song, B. Liu, Y.-H. Gao, L. Ding, Y.-F. Huang, X. Qi
DOI: https://doi.org/10.55563/clinexprheumatol/avcj31
CER14271
2022,40,3
Pg. 0514-0521
Clinical characteristics, outcome and prognostic factors in critically ill patients with lupus nephritis
J. Guo, M. Huang, Z. Ren, Z. Huang, N. Ma, Q. Wang, R. Yin, Z. Zhu, S. Wang, T. Li, S. Liu, Z. Yu
DOI: https://doi.org/10.55563/clinexprheumatol/gsas1t
J. Guo, M. Huang, Z. Ren, Z. Huang, N. Ma, Q. Wang, R. Yin, Z. Zhu, S. Wang, T. Li, S. Liu, Z. Yu
DOI: https://doi.org/10.55563/clinexprheumatol/gsas1t
CER13834
2022,40,3
Pg. 0522-0531
Free to view
Activation of caspase-1 is mediated by stimulation of interferon genes and NLR family pyrin domain containing 3 in monocytes of active systemic lupus erythematosus
S. Inokuchi, H. Mitoma, S. Kawano, M. Ayano, Y. Kimoto, M. Akahoshi, Y. Arinobu, K. Akashi, T. Horiuchi, H. Niiro
DOI: https://doi.org/10.55563/clinexprheumatol/eakvlv
S. Inokuchi, H. Mitoma, S. Kawano, M. Ayano, Y. Kimoto, M. Akahoshi, Y. Arinobu, K. Akashi, T. Horiuchi, H. Niiro
DOI: https://doi.org/10.55563/clinexprheumatol/eakvlv
CER14250
2022,40,3
Pg. 0532-0538
Kimura's disease: clinical characteristics, management and outcome of 20 cases from China
Y. Zhang, H. Bao, X. Zhang, F. Yang, Y. Liu, H. Li, J. Lu, Y. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/lahgfo
Y. Zhang, H. Bao, X. Zhang, F. Yang, Y. Liu, H. Li, J. Lu, Y. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/lahgfo
CER14245
2022,40,3
Pg. 0539-0543
Free to view
Value of contrast-enhanced ultrasonography in assessing the activity of idiopathic retroperitoneal fibrosis: a prospective study
J. Shang, M. Liu, Y. Wang, Y. An, L. An, K. Li, Y. Zhao, J. Zhang, M. Li, J. Zhu
DOI: https://doi.org/10.55563/clinexprheumatol/qie29j
J. Shang, M. Liu, Y. Wang, Y. An, L. An, K. Li, Y. Zhao, J. Zhang, M. Li, J. Zhu
DOI: https://doi.org/10.55563/clinexprheumatol/qie29j
CER14325
2022,40,3
Pg. 0544-0550
Clinical characteristics of axial spondyloarthritis patients in China: results from ChinaSpA, the Chinese Spondyloarthritis Registry
J. Su, R. Wang, X. Duan, Y. Wang, Z. Wu, M. Yang, J. Xu, W. Fan, C. Zhao, Q. Li, X. Wang, J. Zhu, L. Wu, M. Li, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/dybvei
J. Su, R. Wang, X. Duan, Y. Wang, Z. Wu, M. Yang, J. Xu, W. Fan, C. Zhao, Q. Li, X. Wang, J. Zhu, L. Wu, M. Li, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/dybvei
CER14122
2022,40,3
Pg. 0551-0559
Free to view
Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care
F. Behrens, G.-R. Burmester, M. Feuchtenberger, H. Kellner, C. Kuehne, A. Liebhaber, S. Wassenberg, J. Gerlach, M. Zortel, M.W. Hofmann, C. Amberger
DOI: https://doi.org/10.55563/clinexprheumatol/yu55rd
F. Behrens, G.-R. Burmester, M. Feuchtenberger, H. Kellner, C. Kuehne, A. Liebhaber, S. Wassenberg, J. Gerlach, M. Zortel, M.W. Hofmann, C. Amberger
DOI: https://doi.org/10.55563/clinexprheumatol/yu55rd
CER14480
2022,40,3
Pg. 0560-0567
Free to view
The role of pirfenidone in the treatment of interstitial pneumonia with autoimmune features
T. Chen, Q.-H. Li, Y. Zhang, C.-S. Yin, D. Weng, Y. Zhou, Y. Hu, J.-Y. Shi, Y.-N. Chen, S. Ye, X.-D. Wang, C.-Y. Wu, Y. Huang, A.-H. Zhang, H.-P. Li
DOI: https://doi.org/10.55563/clinexprheumatol/off5n7
T. Chen, Q.-H. Li, Y. Zhang, C.-S. Yin, D. Weng, Y. Zhou, Y. Hu, J.-Y. Shi, Y.-N. Chen, S. Ye, X.-D. Wang, C.-Y. Wu, Y. Huang, A.-H. Zhang, H.-P. Li
DOI: https://doi.org/10.55563/clinexprheumatol/off5n7
CER14437
2022,40,3
Pg. 0568-0574
Free to view
Aortic valve surgery in patients with Takayasu's arteritis: a nationwide analysis of 1,197 patients during a 9-year period
S.S. Ahn, M. Han, Y.-B. Park, I. Jung, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/q7z8v5
S.S. Ahn, M. Han, Y.-B. Park, I. Jung, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/q7z8v5
CER14363
2022,40,3
Pg. 0575-0580
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients
M. Radin, E. Rubini, I. Cecchi, S.G. Foddai, A. Barinotti, D. Rossi, S. Sciascia, D. Roccatello
DOI: https://doi.org/10.55563/clinexprheumatol/7vp1bo
M. Radin, E. Rubini, I. Cecchi, S.G. Foddai, A. Barinotti, D. Rossi, S. Sciascia, D. Roccatello
DOI: https://doi.org/10.55563/clinexprheumatol/7vp1bo
CER14213
2022,40,3
Pg. 0581-0588
Long-term survival of renal transplantation in patients with lupus nephritis: experience from a single university centre
D. Martínez-López, L. Sánchez-Bilbao, M. De cos-Gómez, I. González-Mazón, E. Rodrigo-Calabia, J.C. Ruiz-San millán, J. Gómez Román, S. Castañeda, M.A. González-Gay, J.L. Hernández, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/ri873i
D. Martínez-López, L. Sánchez-Bilbao, M. De cos-Gómez, I. González-Mazón, E. Rodrigo-Calabia, J.C. Ruiz-San millán, J. Gómez Román, S. Castañeda, M.A. González-Gay, J.L. Hernández, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/ri873i
CER14376
2022,40,3
Pg. 0589-0595
Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high with worsening of patient-related outcomes
R. Thalmann, J. Von Kempis, A. Zgraggen, N. Graf, M. Schiff, T. Sokka, T. Dietrich, H. Schulze-Koops, R.B. Mueller
DOI: https://doi.org/10.55563/clinexprheumatol/jpysud
R. Thalmann, J. Von Kempis, A. Zgraggen, N. Graf, M. Schiff, T. Sokka, T. Dietrich, H. Schulze-Koops, R.B. Mueller
DOI: https://doi.org/10.55563/clinexprheumatol/jpysud
CER14289
2022,40,3
Pg. 0596-0607
Upregulation of antigen presentation function and inflammation in chondrocytes by induction of proteoglycan aggrecan peptides (P16-31 and P263-280)
P. Sengprasert, N. Leearamwat, S. Ngarmukos, P. Yuktananda, A. Tanavalee, R. Reantragoon
DOI: https://doi.org/10.55563/clinexprheumatol/hjzqfs
P. Sengprasert, N. Leearamwat, S. Ngarmukos, P. Yuktananda, A. Tanavalee, R. Reantragoon
DOI: https://doi.org/10.55563/clinexprheumatol/hjzqfs
CER14652
2022,40,3
Pg. 0608-0612
Free to view
SARS-CoV-2 in the knee joint: a cadaver study
M. Grassi, V. Giorgi, M. Nebuloni, P. Zerbi, M.R. Gismondo, F. Salaffi, P. Sarzi-Puttini, S.G. Rimoldi, A. Manzotti
DOI: https://doi.org/10.55563/clinexprheumatol/t1m4y2
M. Grassi, V. Giorgi, M. Nebuloni, P. Zerbi, M.R. Gismondo, F. Salaffi, P. Sarzi-Puttini, S.G. Rimoldi, A. Manzotti
DOI: https://doi.org/10.55563/clinexprheumatol/t1m4y2
CER14423
2022,40,3
Pg. 0613-0619
Free to view
The elevation of serum uric acid depends on insulin resistance but not fasting plasma glucose in hyperuricaemia
Y. Liu, W. Li, J. Chen, H. Guo, B. Wang, Z. Ni, T. Hu, Z. Sun, S. Qiu
DOI: https://doi.org/10.55563/clinexprheumatol/qayjr5
Y. Liu, W. Li, J. Chen, H. Guo, B. Wang, Z. Ni, T. Hu, Z. Sun, S. Qiu
DOI: https://doi.org/10.55563/clinexprheumatol/qayjr5
CER14243
2022,40,3
Pg. 0620-0624
Secukinumab in the treatment for patients with juvenile enthesitis related arthritis non-responsive to anti-TNF treatment according the Juvenile Spondyloarthritis Disease Activity Index
J. Baer, J. Klotsche, I. Foeldvari
DOI: https://doi.org/10.55563/clinexprheumatol/1u8y08
J. Baer, J. Klotsche, I. Foeldvari
DOI: https://doi.org/10.55563/clinexprheumatol/1u8y08
CER14511
2022,40,3
Pg. 0625-0630
Clinical characteristics of anti-isoleucyl-tRNA synthetase antibody associated syndrome and comparison with different patient cohorts
Y.P. Ge, Y.L. Zhang, X.M. Shu, X. Lu, G.C. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/v2rbd0
Y.P. Ge, Y.L. Zhang, X.M. Shu, X. Lu, G.C. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/v2rbd0
Brief Paper
CER15163
2022,40,3
Pg. 0631-0633
Free to view
The relationship between metabolic syndrome severity and the risk of mortality in gout patients: a population-based study
N. Schlesinger, M.I. Elsaid, V.K. Rustgi
DOI: https://doi.org/10.55563/clinexprheumatol/2rn9fv
N. Schlesinger, M.I. Elsaid, V.K. Rustgi
DOI: https://doi.org/10.55563/clinexprheumatol/2rn9fv
Reviews
CER14618
2022,40,3
Pg. 0634-0646
Free to view
Efficacy and safety of tocilizumab in the management of COVID-19: a systematic review and meta-analysis of observational studies
G.L. Viswanatha, C. Anjana Male, H. Shylaja
DOI: https://doi.org/10.55563/clinexprheumatol/4dg0or
G.L. Viswanatha, C. Anjana Male, H. Shylaja
DOI: https://doi.org/10.55563/clinexprheumatol/4dg0or
CER14704
2022,40,3
Pg. 0647-0654
Free to view
Research progress on the pathogenesis and quality of life of patients with primary Sjögren’s syndrome complicated by depression
T. Huang, Y. Li, Y. Luo, Y. Zhou, Y. Zhao, Y. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/nspi47
T. Huang, Y. Li, Y. Luo, Y. Zhou, Y. Zhao, Y. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/nspi47
Paediatric Rheumatology
CER14504
2022,40,3
Pg. 0655-0661
Free to view
The paediatric foot: prevalence and differentiation of sonographic and podiatric findings in juvenile arthritis and healthy children
P. Collado, M.L. González-Fernández
DOI: https://doi.org/10.55563/clinexprheumatol/ce8qcj
P. Collado, M.L. González-Fernández
DOI: https://doi.org/10.55563/clinexprheumatol/ce8qcj
Letters to the Editor
CER14841
2022,40,3
Pg. 0662-0663
Free to view
The decrease of Kawasaki syndrome during the second COVID-19 wave: a potential, unexpected effect of social distancing
M.V. Mastrolia, R. Agostiniani, C. Azzari, R. Bernardini, U. Bottone, G.B. Calabri, F. Civitelli, R. Consolini, R. Danieli, R. Di Silvio, S. Falorni, L. Gagliardi, S. Grosso, G. Indolfi, M. L'erario, M. Martini, G. Memmini, D. Peroni, M. Pezzati, G. Suriano, L. Tafi, S. Trapani, A. Vaccaro, P.L. Vasarri, S. Gabriele
on behalf of the Paediatric Tuscany Network
DOI: https://doi.org/10.55563/clinexprheumatol/41r3mt
M.V. Mastrolia, R. Agostiniani, C. Azzari, R. Bernardini, U. Bottone, G.B. Calabri, F. Civitelli, R. Consolini, R. Danieli, R. Di Silvio, S. Falorni, L. Gagliardi, S. Grosso, G. Indolfi, M. L'erario, M. Martini, G. Memmini, D. Peroni, M. Pezzati, G. Suriano, L. Tafi, S. Trapani, A. Vaccaro, P.L. Vasarri, S. Gabriele
on behalf of the Paediatric Tuscany Network
DOI: https://doi.org/10.55563/clinexprheumatol/41r3mt
CER14606
2022,40,3
Pg. 0664-0665
Free to view
Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?
Z. Layegh, F. Hooijberg, C. Bastida, A.D. Huitema, T. Rispens, C.G. Wolbink
DOI: https://doi.org/10.55563/clinexprheumatol/xn5i2y
Z. Layegh, F. Hooijberg, C. Bastida, A.D. Huitema, T. Rispens, C.G. Wolbink
DOI: https://doi.org/10.55563/clinexprheumatol/xn5i2y
CER15152
2022,40,3
Pg. 0666
Free to view
Fever at diagnosis as a confounding factor in patients with polymyalgia rheumatica. Messages from primary care. Comments on Betrains et al.
C. Manzo, M. Natale
DOI: https://doi.org/10.55563/clinexprheumatol/j2r9je
C. Manzo, M. Natale
DOI: https://doi.org/10.55563/clinexprheumatol/j2r9je
CER15158
2022,40,3
Pg. 0667
Free to view
Implications of fever on erythrocyte sedimentation rate but not on C-reactive protein concentrations at the time of diagnosis of polymyalgia rheumatica. Comments on Betrains et al.
M. Milchert, A. Castagna, C. Manzo, M. Brzosko
DOI: https://doi.org/10.55563/clinexprheumatol/8u94jp
M. Milchert, A. Castagna, C. Manzo, M. Brzosko
DOI: https://doi.org/10.55563/clinexprheumatol/8u94jp
CER15216
2022,40,3
Pg. 0668
Free to view
Clinical implications of fever at diagnosis in polymyalgia rheumatica: an age- and sex-matched case control study of 120 patients. Reply to Milchert et al. and Manzo et al.
A. Betrains, L. Boeckxstaens, K. Van Laere, S. Vanderschueren, D. Blockmans
DOI: https://doi.org/10.55563/clinexprheumatol/6uezpq
A. Betrains, L. Boeckxstaens, K. Van Laere, S. Vanderschueren, D. Blockmans
DOI: https://doi.org/10.55563/clinexprheumatol/6uezpq
CER15148
2022,40,3
Pg. 0669-0670
Free to view
The negative impact of undiagnosed depression in axial spondyloarthropathy
S. Maguire, P. Gallagher, F. O'shea
DOI: https://doi.org/10.55563/clinexprheumatol/d6518k
S. Maguire, P. Gallagher, F. O'shea
DOI: https://doi.org/10.55563/clinexprheumatol/d6518k
CER14851
2022,40,3
Pg. 0671-0672
Free to view
Lupus-like disease and progressive multifocal leukoencephalopathy following etanercept treatment: just a coincidence?
V.E. Papadopoulos, G. Velonakis, T. Argyrakos, M. Anagnostouli, L. Stefanis, C.P. Mavragani, M.-E. Evangelopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/cfg3tk
V.E. Papadopoulos, G. Velonakis, T. Argyrakos, M. Anagnostouli, L. Stefanis, C.P. Mavragani, M.-E. Evangelopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/cfg3tk